BKWO yields 0.60% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, BKWO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKWO + JNJ for your $10,000?
The fund seeks long-term capital growth, and looks to invest principally in U.S. companies that have attractive financial attributes and promote "women's opportunities" - opportunities that can enhance the professional development and advancement of women and/or the ability of women to meet their work or other personal life responsibilities. The fund considers companies that promote women's opportunities to be companies that demonstrate gender equity practices in the workplace and/or that provide products or services that are believed to enhance the lives of women, including female participation in management and board representation, positive benefit programs including family leave and flexible work arrangements, as well as companies that offer products /services that help women meet daily life needs. Provides investors with a growth-oriented investment with the added focus on gender equality and supporting women's opportunities. BNY Mellon ETF Investment Adviser, LLC will make contributions to one or more charitable organizations which seeks to promote opportunities for women and/or girls, in an amount representing at least 10% annually of the management fee. Liquid ETF structure allows investors to buy or sell any time the market is open.
Full BKWO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.